Related Experiment Video
Updated: Feb 27, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Small fiber neuropathy: a disabling and underrecognized syndrome
Mareye Voortman1, Daan Fritz, Oscar J M Vogels
1aDepartment of Pulmonology, ILD Center of Excellence, St. Antonius Hospital, Nieuwegein bDivision of Heart & Lungs, Department of Pulmonology, University Medical Centre Utrecht, Utrecht cDepartment of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam Neuroscience, Amsterdam dDepartment of Neurology, ILD Center of Excellence, St. Antonius Hospital, Nieuwegein eDepartment of Pharmacology and Toxicology, FHML, Maastricht University, Maastricht, The Netherlands.
Small fiber neuropathy (SFN) presents diagnostic challenges due to varied symptoms and limited tests. Early recognition of SFN is crucial for patient benefit, even without specific treatments.
Area of Science:
- Neurology
- Clinical Medicine
Background:
- Small fiber neuropathy (SFN) significantly impacts patient quality of life.
- Diagnosis of SFN is often challenging and can be overlooked.
- Recent research identifies genetic mutations as a potential cause of SFN.
Purpose of the Study:
- To review the causes, clinical manifestations, diagnostic approaches, and treatment options for SFN.
- To highlight the difficulties in diagnosing SFN and its clinical relevance.
- To emphasize the need for increased awareness and diagnostic guidelines for SFN.
Main Methods:
- Review of current literature on small fiber neuropathy.
- Analysis of proposed clinical diagnostic criteria.
- Discussion of diagnostic limitations and the need for a combination of tests.
- Examination of treatment strategies, focusing on symptomatic relief.
Main Results:
- SFN leads to high morbidity and disabling symptoms.
- No definitive gold standard diagnostic test exists for SFN.
- Diagnosis requires correlating symptoms, neurological findings, and exclusion of large fiber involvement.
- Treatment is often symptomatic, with limited options even when the cause is known.
Conclusions:
- Increased clinical awareness of SFN and its overlapping symptoms with conditions like fibromyalgia is essential.
- Development of guidelines for a stepwise diagnostic workup is warranted.
- Timely recognition of SFN offers patient benefit, irrespective of available treatments.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease IV: Nursing Management
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Nephrotic Syndrome I : Introduction

